Thyroid Disorders: Hypothyroidism, Hyperthyroidism, and How They Affect Women

The Thyroid Gland: A Small Gland with Outsized Influence

The thyroid gland is a small, butterfly-shaped gland located at the base of the neck, in front of the trachea. Despite its modest size—typically weighing only 20 to 30 grams—the thyroid has a profound influence on virtually every system in the body. The thyroid produces two primary hormones: thyroxine (T4) and triiodothyronine (T3), which together regulate the body's metabolic rate, heart rate, body temperature, mood, digestion, muscle function, bone maintenance, and brain development. When the thyroid functions normally, these hormones are produced in carefully calibrated amounts governed by a feedback loop involving the pituitary gland and hypothalamus. When thyroid function is disrupted—too much or too little hormone production—the effects can be widespread, affecting virtually every organ and system in the body.

Thyroid disorders are among the most common endocrine conditions worldwide, affecting an estimated 20 million Americans. Women are five to eight times more likely than men to have a thyroid disorder, and the lifetime risk for a woman of developing some form of thyroid disease is estimated at one in eight. This striking sex disparity reflects the influence of female hormones on thyroid function, the higher prevalence of autoimmune thyroid disease in women, and the additional thyroid stress imposed by pregnancy and hormonal fluctuations across the reproductive lifespan. Understanding thyroid disorders is particularly important for women because unrecognized or undertreated thyroid disease can affect fertility, pregnancy outcomes, mood, energy, weight, and cardiovascular health.

The major categories of thyroid disorder include hypothyroidism (underactive thyroid, producing too little hormone), hyperthyroidism (overactive thyroid, producing too much hormone), thyroid nodules (lumps in the thyroid that may be benign or malignant), and thyroid cancer. This article focuses primarily on hypothyroidism and hyperthyroidism—the conditions that most commonly affect women—though it will touch on the diagnostic evaluation that applies across thyroid disorders. Both hypothyroidism and hyperthyroidism are highly treatable when recognized, and most affected women can achieve excellent thyroid control and quality of life with appropriate management.

Hypothyroidism: When the Thyroid Is Underactive

Hypothyroidism is the most common thyroid disorder, affecting an estimated 4.6 percent of the U.S. population, with significantly higher prevalence in women and in older adults. In hypothyroidism, the thyroid gland does not produce enough thyroid hormone to meet the body's needs, resulting in a slowing of virtually all metabolic processes. The symptoms of hypothyroidism typically develop gradually over months or years, which means many people attribute them to aging, stress, or other causes rather than recognizing them as a potentially treatable thyroid condition. This gradual onset contributes to the significant underdiagnosis of hypothyroidism.

The symptoms of hypothyroidism are diverse and can affect nearly every system in the body. The most common include persistent fatigue and sluggishness despite adequate sleep, weight gain or difficulty losing weight despite unchanged diet and exercise habits, cold intolerance (feeling cold when others are comfortable), constipation, dry skin and brittle nails, thinning hair or hair loss, slowed heart rate, muscle weakness or aches, depression and cognitive slowing (sometimes called "brain fog"), irregular or heavy menstrual periods, and—in severe or longstanding cases—puffiness of the face and hands. The severity of symptoms generally correlates with the degree of hormone deficiency, and milder cases may cause only subtle or nonspecific complaints.

The most common cause of hypothyroidism in iodine-sufficient countries is Hashimoto's thyroiditis (also called Hashimoto's disease or autoimmune thyroiditis), an autoimmune condition in which the immune system produces antibodies that attack the thyroid gland, leading to progressive thyroid inflammation and destruction. Hashimoto's affects women 7 to 10 times more often than men and is the leading cause of hypothyroidism in the United States. Other causes include radioactive iodine treatment or surgery for hyperthyroidism or thyroid cancer, certain medications (including lithium and amiodarone), iodine deficiency (the leading cause worldwide, though less common in developed countries), and secondary hypothyroidism caused by pituitary or hypothalamic disease. Subclinical hypothyroidism—defined by elevated TSH with normal T4, often without overt symptoms—is particularly common in older women and is a subject of ongoing debate regarding the threshold for treatment.

Hyperthyroidism: When the Thyroid Is Overactive

Hyperthyroidism occurs when the thyroid gland produces excessive thyroid hormone, accelerating the body's metabolic processes. It is less common than hypothyroidism but can be more dramatic in its presentation. Hyperthyroidism affects approximately 1.2 percent of the U.S. population and, like hypothyroidism, is significantly more common in women. The symptoms of hyperthyroidism are essentially the opposite of hypothyroidism: rather than metabolic slowing, there is metabolic acceleration manifesting as anxiety, irritability, and emotional lability; unintentional weight loss despite increased appetite; heat intolerance and excessive sweating; rapid or irregular heartbeat (palpitations); tremor of the hands; increased frequency of bowel movements or diarrhea; difficulty sleeping; and light or absent menstrual periods.

The most common cause of hyperthyroidism in developed countries is Graves' disease, another autoimmune thyroid condition in which immune antibodies (TSH receptor antibodies) stimulate the thyroid to produce excess hormone. Graves' disease affects women approximately 7 to 10 times more often than men and typically occurs in women between 20 and 50 years of age. A distinctive feature of Graves' disease is Graves' ophthalmopathy—a condition in which inflammation affects the tissues surrounding the eyes, causing eye bulging (proptosis), eye redness and irritation, double vision, and in severe cases, vision loss. Graves' ophthalmopathy can occur independently of the thyroid disease and may persist even after the hyperthyroidism is treated.

Other causes of hyperthyroidism include toxic multinodular goiter (in which multiple thyroid nodules produce excess hormone), toxic adenoma (a single autonomous thyroid nodule), thyroiditis (inflammation of the thyroid that can transiently release stored hormone), and excessive iodine intake from medications or contrast agents. Postpartum thyroiditis—a form of thyroid inflammation that occurs in the months after delivery—can cause a transient phase of hyperthyroidism followed by hypothyroidism before the thyroid recovers, or can result in permanent hypothyroidism. This condition affects approximately 5 to 10 percent of women and is more common in those with a history of autoimmune thyroid disease or type 1 diabetes.

Diagnosing Thyroid Disorders: Tests and Interpretation

The primary blood test for evaluating thyroid function is the thyroid-stimulating hormone (TSH) test. TSH is produced by the pituitary gland in response to thyroid hormone levels: when thyroid hormone levels are low, the pituitary secretes more TSH to stimulate the thyroid to produce more hormone; when thyroid hormone levels are high, TSH secretion is suppressed. For most thyroid disorders, TSH is the single best initial screening test: an elevated TSH indicates hypothyroidism, and a suppressed TSH indicates hyperthyroidism. The sensitivity of the TSH test for detecting thyroid dysfunction is excellent, and it is the standard first-line test in clinical practice.

When TSH is abnormal, additional tests are typically ordered to characterize the extent and cause of the abnormality. Free T4 (the unbound, biologically active form of thyroxine) is measured to assess the degree of hormone deficiency or excess. Free T3 may also be measured, particularly in hyperthyroidism where T3 toxicosis (elevated T3 with normal T4) can occur. Thyroid antibody tests—including anti-thyroid peroxidase (anti-TPO) antibodies and anti-thyroglobulin antibodies—can confirm autoimmune thyroid disease (Hashimoto's or Graves'). TSH receptor antibodies (TRAb) are specific for Graves' disease and are particularly useful when the diagnosis is uncertain. Thyroid ultrasound provides anatomical information about the size and structure of the gland and can detect nodules, while radioactive iodine uptake scans can help distinguish different causes of hyperthyroidism.

The normal range for TSH is a subject of some debate among endocrinologists. The conventional laboratory reference range is typically quoted as 0.4 to 4.0 mIU/L, though some experts argue that the upper limit should be lower (around 2.5 mIU/L) and that values above this threshold in symptomatic patients may warrant treatment. This debate is particularly relevant for women experiencing symptoms that could be consistent with hypothyroidism and who have TSH values in the upper end of the conventional normal range. Women who feel their symptoms are not being adequately explained by their laboratory results should discuss their concerns with their healthcare provider and may benefit from consultation with an endocrinologist.

Treatment Approaches for Hypothyroidism and Hyperthyroidism

The treatment of hypothyroidism is straightforward and highly effective: oral replacement with levothyroxine, a synthetic form of T4, is the standard of care. Levothyroxine is taken once daily, typically in the morning on an empty stomach, and restores normal thyroid hormone levels in virtually all patients. The dose is individualized based on weight, age, the severity of hypothyroidism, and patient response, and adjusted periodically based on TSH measurements. Most patients on appropriate levothyroxine doses achieve full symptom resolution. Some patients on levothyroxine continue to experience symptoms despite normalized TSH levels; for these patients, addition of a small amount of liothyronine (synthetic T3) may provide additional benefit, though this approach is not universally accepted and requires careful monitoring.

The treatment of hyperthyroidism offers three main options: antithyroid medications, radioactive iodine therapy, and thyroidectomy. Antithyroid drugs—primarily methimazole (Tapazole) in the United States—block the thyroid's ability to produce new hormone and can achieve remission in a significant proportion of Graves' disease patients, particularly those with mild disease. They are typically used for 12 to 18 months, and approximately 30 to 40 percent of patients remain in remission after discontinuation, while others relapse and require definitive treatment. Radioactive iodine therapy involves swallowing a capsule or liquid containing radioactive iodine, which is selectively taken up by thyroid cells and destroys them. This results in permanent hypothyroidism in most patients, who then require lifelong levothyroxine. Thyroidectomy—surgical removal of all or most of the thyroid—provides immediate resolution of hyperthyroidism and is particularly appropriate for patients with large goiters, Graves' ophthalmopathy, or suspected thyroid cancer, and for women who are pregnant or planning pregnancy in the near term.

Thyroid Disorders, Fertility, and Pregnancy

Thyroid function has a significant impact on reproductive health. Both hypothyroidism and hyperthyroidism can impair fertility and increase the risk of miscarriage, preterm birth, and other pregnancy complications. Women who are having difficulty conceiving or who have experienced recurrent pregnancy loss should have their thyroid function evaluated. Thyroid dysfunction can disrupt the hormonal signals that regulate ovulation, alter uterine receptivity, and impair fetal development in the critical early weeks of pregnancy before the fetal thyroid begins to function.

During pregnancy, the demand for thyroid hormone increases by approximately 30 to 50 percent, because the mother must supply thyroid hormone for both herself and the developing fetus (which cannot produce its own thyroid hormone until the second trimester). Women with pre-existing hypothyroidism typically need to increase their levothyroxine dose during pregnancy, often substantially. The dose should be adjusted based on trimester-specific TSH targets that are more stringent than the non-pregnant reference range. Uncontrolled hypothyroidism during pregnancy is associated with intellectual impairment in the child, underscoring the importance of careful thyroid monitoring and dose adjustment throughout pregnancy.

Postpartum thyroid dysfunction—including the transient thyroiditis that can cause hypo- or hyperthyroidism in the months after delivery—requires awareness and monitoring, particularly in women with known autoimmune thyroid disease or a history of postpartum thyroid dysfunction. Women experiencing unexplained fatigue, mood changes, or other postpartum symptoms should have their thyroid function evaluated, as postpartum thyroiditis is common, often unrecognized, and easily treated. Women who have had Graves' disease should be aware that hyperthyroidism can recur or worsen in the postpartum period. Overall, careful thyroid management throughout the reproductive lifespan is an important component of women's health care, requiring awareness from both patients and their healthcare providers.